MDM2 and myocardial infarction: After myocardial infarction, the upregulation of MDM2 protein expression in mouse hearts is significantly attenuated by treatment with the MDM2 inhibitor Nutlin-3a, which inhibits NF-κB activation, blocks pro-inflammatory cytokine production, and improves cardiac function while reducing cardiac fibrosis.